U.S. flag

An official website of the United States government

NM_000155.4(GALT):c.403T>G (p.Ser135Ala) AND Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 13, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002022361.6

Allele description [Variation Report for NM_000155.4(GALT):c.403T>G (p.Ser135Ala)]

NM_000155.4(GALT):c.403T>G (p.Ser135Ala)

Gene:
GALT:galactose-1-phosphate uridylyltransferase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9p13.3
Genomic location:
Preferred name:
NM_000155.4(GALT):c.403T>G (p.Ser135Ala)
HGVS:
  • NC_000009.12:g.34647857T>G
  • NG_009029.2:g.6269T>G
  • NG_028966.1:g.673T>G
  • NM_000155.4:c.403T>GMANE SELECT
  • NM_001258332.2:c.76T>G
  • NP_000146.2:p.Ser135Ala
  • NP_001245261.1:p.Ser26Ala
  • NC_000009.11:g.34647854T>G
Protein change:
S135A
Links:
dbSNP: rs2132343082
NCBI 1000 Genomes Browser:
rs2132343082
Molecular consequence:
  • NM_000155.4:c.403T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001258332.2:c.76T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
Synonyms:
GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE DEFICIENCY; Galactose-1-phosphate uridyltransferase deficiency; Transferase Deficiency Galactosemia; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009258; MedGen: C0268151; Orphanet: 352; Orphanet: 79239; OMIM: 230400

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002296368Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Feb 13, 2021)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification and functional analysis of three distinct mutations in the human galactose-1-phosphate uridyltransferase gene associated with galactosemia in a single family.

Fridovich-Keil JL, Langley SD, Mazur LA, Lennon JC, Dembure PP, Elsas JL 2nd.

Am J Hum Genet. 1995 Mar;56(3):640-6.

PubMed [citation]
PMID:
7887417
PMCID:
PMC1801186

Nine years of newborn screening for classical galactosemia in the Netherlands: Effectiveness of screening methods, and identification of patients with previously unreported phenotypes.

Welling L, Boelen A, Derks TG, Schielen PC, de Vries M, Williams M, Wijburg FA, Bosch AM.

Mol Genet Metab. 2017 Mar;120(3):223-228. doi: 10.1016/j.ymgme.2016.12.012. Epub 2016 Dec 29.

PubMed [citation]
PMID:
28065439
See all PubMed Citations (8)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002296368.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

This variant is not present in population databases (ExAC no frequency). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Ser135 amino acid residue in GALT. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 7887417, 28065439, 22944367, 22461411, 27176039, 11152465, 12208137). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GALT protein function. This variant has not been reported in the literature in individuals with GALT-related conditions. This sequence change replaces serine with alanine at codon 135 of the GALT protein (p.Ser135Ala). The serine residue is highly conserved and there is a moderate physicochemical difference between serine and alanine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024